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One of the goals of protein engineering is to tailor the structure of enzymes to optimize industrial bioprocesses.
In the present work, we present the construction of a novel high molecular weight subtilisin, based on the fusion
of the DNA sequences coding for Bacillus subtilis prosubtilisin E and for an elastin-like polymer (ELP). The
resulting fusion protein was biologically produced in Escherichia coli, purified and used for wool finishing assays.
When compared to the commercial protease Esperase, the recombinant subtilisinE-VPAVG220 activity was restricted
to the cuticle of wool, allowing a significant reduction of pilling, weight loss and tensile strength loss of wool
fibers. Here we report, for the first time, the microbial production of a functionalized high molecular weight
protease for controlled enzymatic hydrolysis of wool surface. This original process overcomes the unrestrained
diffusion and extended fiber damage which are the major obstacles for the use of proteases for wool finishing
applications.
Introduction
The morphology of wool is highly complex, not only at the
fiber stem but also at the surface. It is, in fact, the surface
morphology that plays a major role in the wool processing for
textile industry. Unwanted effects such as shrinkage, felting,
and limited diffusion of dyes and other finishing compounds
are most probably due to the presence of wool scales at the
fiber surface.1 These scales must be removed for an efficient
finishing and to provide resistance to felting and shrinkage.
Chlorine oxidation is conventionally used, but loss of fabric
strength and negative ecological impact precludes its accepta-
bility.2,3 There have been several attempts to replace this
chlorine process by proteases to degrade scales providing wool
with antifelting and antishrinkage characteristics.4,5 However,
enzymatic reactions need to be controlled to avoid undesirable
effects, especially enzyme diffusion into wool cortex and
consequent fiber damage. In principle, unrestrained diffusion
problems may be overcome increasing protease molecular
weight by chemical modification.6-8 Chemical modification
relates to an alteration of chemical structure and can be
conducted by cross-linking of protease with glutaraldehyde or
by the attachment of synthetic polymers like polyethylene
glycol.6-8 However, due to the presence of residual free enzyme,
wool degradation still occurs, though to a less extent.8
In the present work, we engineered, produced and character-
ized a subtilisin E fused with an elastin-like polymer (ELP),
resulting in a high molecular weight recombinant protein. The
ELP gene used is based on 220 repetitions of the monomeric
sequence VPAVG, previously constructed in our laboratory.9
Subtilisin E from Bacillus subtilis, is first synthesized as a
prepro-subtilisin with the 29 amino acid residues presequence
serving as a signal peptide for secretion from the cell. Upon
cleavage of the presequence, the prosubtilisin E undergoes
cleavage either autocatalytically or by existing active subtilisin
E to produce active mature enzyme.10 Based on literature data,
our ELP polymer sequence is not a substrate for subtilisin E.11,12
Here we compare the behavior of two proteases, the com-
mercially available low molecular weight Esperase, and the
recombinant high molecular weight subtilisinE-VPAVG220, in
the diffusion and hydrolytic attack to wool fibers.
Materials and Methods
Bacterial Strains, Plasmids, and Enzymes. The Escherichia coli
strain BL21(DE3), the T7 plasmid pET25b (+) and Overnight Express
Instant TB medium were purchased from Novagen (Madison WI).
Restriction and modification enzymes were from Roche Applied Science
(Germany). The commercial enzyme used in this study was the protease
Esperase (E.C.3.4.21.62) from Sigma-Aldrich. Unless specifically stated,
all the other reagents were from Sigma-Aldrich (St. Louis MO).
Wool Material. Untreated pure wool woven fabrics and yarns of
23 µm (mean diameter) were provided by Albano Antunes Morgado
Lda, Portugal.
Gene Synthesis. The DNA coding for the peptide monomer
containing 10 repetitions of VPAVG was chemically synthesized and
subjected to concatenation. The multimeric block genes (flanked by
Eam1104I recognition sites) were obtained by directional ligation in
the cloning vector pDrive (Qiagen, Hilden, Germany), resulting in the
construction pDrive:VPAVG220. Construction was confirmed with the
restriction enzymes Eam1104I and EcoRI (Fermentas, St. Leon-Rot,
Germany). This strategy was previously described and reported as the
“Gutenberg Method”.13,14 The construction pDrive-VPAVG220 was
digested with MboII. The fragment MboII-VPAVG220-MboII was
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Klenow blunted and purified from a 1% (w/v) agarose gel electro-
phoresis. After DNA extraction, the gene was cloned into the XhoI
digested, Klenow blunted, and dephosphorilated pET25b:prosubtil-
isinE,15 resulting in the final construction pET25:prosubtilisinE-
VPAVG220. This vector was used to transform E. coli strain XL1 Blue,
according to the Simple and Efficient Method.16 The plasmid construct
was verified by restriction analysis with LguI and by DNA sequencing,
following the method of Sanger17 using an ABI PRISM 310 Genetic
Analyzer. DNA cloning and manipulation were performed according
to the standard protocols.18 The recombinant plasmids were then
transformed into the expression strain E. coli BL21(DE3) (Novagen).
Protein Expression and Purification. A single colony of E. coli
BL21(DE3) harboring pET25:prosubtilisinE-VPAVG220 was inoculated
at 30 °C, overnight, in Novagen Autoinduction medium, containing
100 µg/mL ampicillin. Cells were harvested by centrifugation at 3000
× g for 10 min, washed with phosphate buffered saline solution (PBS;
10 mM Na2HPO4, 2 mM KH2PO4, 137 mM NaCl, 3 mM KCl, pH
7.4), and lysed by ultrasonic disruption. Ultrasonic treatment was
performed at 120 Watts with a 25 mm probe in an Ultrasonic Processor
GEX400. Four 2 min pulses, with 2 min on ice between each pulse,
were performed. Cellular lysate was centrifuged at 15400 × g for 30
min at 4 °C. Supernatant was reserved for protein purification and the
pellet, insoluble debris, was resuspended in PBS and reserved for
analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). Recombinant protein was purified using an immobilized
metal affinity chromatography (IMAC) system with a HisPrep FF 16/
10 column (GE Healthcare) already prepacked with precharged Ni
Sepharose 6 Fast Flow. Column equilibration was performed with 10
mM imidazole, 0.5 M NaCl, and 20 mM phosphate buffer, pH 7.6.
Samples were applied onto the column at a flow rate of 2 mL/min.
Elution was performed with a buffer containing 80 mM imidazole, 0.5
M NaCl, and 20 mM phosphate buffer, pH 7.6.
Protein Electrophoresis and Protease Activity. Proteins were
detected by SDS-PAGE using a Tris-SDS-glycine buffer system.19 SDS
PAGE gel images were acquired with Molecular Imager ChemiDoc
XRS system and Quantity One software from Biorad. Protein detection
was done by Coomassie Brilliant Blue R250. Protease activity of
commercial Esperase and recombinant subtilisinE-VPAVG220 was
measured using casein as substrate.6 One unit of activity is defined as
the amount of enzyme that hydrolyses casein to produce equivalent
color to 1 µmol of Tyrosine, per minute, at pH 7.5 and 37 °C (color by
the Folin and Ciocalteu’s reagent). Target protein concentration was
determined by a modification of the micro Lowry method20 using
bovine serum albumin as standard and using Sigma test kit no. P5656.
Differential Scanning Calorimetry (DSC). DSC experiments of
subtilisinE-VPAVG220 were performed on a Mettler Toledo DSC822e.
Liquid nitrogen was used as cooler and the calibration of enthalpy and
temperature was performed with indium (In) and zinc (Zn). The analyses
Figure 1. (A) DSC run with 25 mg/mL subtilisinE-VPAVG220 solution in water. (B) SEM image showing the disordered state of lyophilized
subtilisinE-VPAVG220 before the particle preparation (see Materials and Methods), below the Tt. (C) SEM image showing the size and shape of
aggregates formed during the particle preparation (see Materials and Methods) above the Tt.
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were carried with 25 mg/mL of subtilisinE-VPAVG220 in deionized
water. In a typical DSC run, 25 µL of polymer solution were placed in
a hermetically sealed aluminum pan and studied under a four-stage
thermal program. First, the sample was pretreated 15 min at 4 °C,
followed by a heating stage (HS) from 4 to 60 °C with a constant heating
rate of +10 °C/min. The sample was maintained at 60 °C for 3 min
and cooled down in a cooling stage (CS) to 4 °C with a constant cooling
rate of -10 °C/min. The onset value was calculated with the provided
STARe software.
Preparation and Morphological Characterization of SubtilisinE-
VPAVG220 Particles. A solution of 5 mg/mL of subtilisinE-VPAVG220
in water was treated at 50 °C over 40 min. Particles were formed by
polymer self-aggregation from aqueous solution. The solution was then
centrifuged at 16000 × g and the supernatant was discarded. The pellet
was finally dried at 37 °C overnight.
Fluorescein Isothiocyanate (FITC) Linkage to Proteins. Enzymes
were linked to FITC (100/1, w/w) in sodium carbonate buffer, pH 8.5.
Free FITC was removed using HiTrap desalting columns (Amersham).
Wool samples were incubated in each of these solutions at 37 °C and
20 rpm, for 24 h. Wool fibers cross sections were analyzed on a Leica
Microsystems DM-5000B epifluorescence microscope with appropriate
filter settings using a 100× oil-immersion objective. Images were
acquired with a Leica DCF350FX digital camera and processed with
LAS AF Leica Microsystems software.
Enzymatic Treatment of Wool Yarns. Before enzymatic treatment,
wool yarns were subjected to two different pretreatments: Scouring
(S): wool was washed with 1 g/L of surfactant Lutensol AT 25 (BASF,
Germany) in a bath ratio of 1:20 at pH 9.0 (Na2CO3 0.1 M and NaHCO3
0.1 M buffer) for 30 min at 40 °C in a Rotawash machine. The
surfactant was removed from wool first with tap water, followed by
distilled water. Bleaching (S + B): after scouring, wool was immersed
in a bath with 1% (of weight of fabric) H2O2 at pH 9.0 (Na2CO3 0.1 M
and NaHCO3 0.1 M buffer) for 1 h at 55 °C in a Rotawash machine.
Enzymatic treatment was performed in plastic tubes containing 0.5 g
of wool yarns, subjected to the different pretreatments described above
and 0.85 U of commercial or recombinant protease in 50 mL of 0.01
M phosphate buffer solution (pH 7.6). The tubes were incubated at 37
°C and 90 rpm in a shaking water bath for 24 h. Several controls were
run simultaneously: a control test wool without pretreatment (control),
a control test with surfactant washed wool (control, S) and a control
test with bleached wool (control, S + B), all without protein. After
incubation, wool yarns were removed and washed with Lutensol AT
25 and water for tensile strength, felting, and pilling evaluation.
Enzymatic Treatment of Wool Fabrics. Woven fabrics of 100%
wool were scoured using a procedure identical to that used for wool
yarns but in liquor to fiber ratio of 1:100. The fabrics were rinsed with
tap water followed by distilled water. Enzymatic treatment of scoured
wool fabrics was performed with 0.85 U of commercial or recombinant
protease in 0.3 M Tris-HCl buffer with 0.03 M CaCl2, pH 7.6.
Treatments were conducted at 50 °C and 70 rpm (orbital agitation) for
5 h. After incubation, wool fabrics were removed and washed. The
remaining solution was centrifuged and the amount of amino acids
produced was measured in terms of tyrosine equivalents.21
Weight Loss. Wool fabrics were dried at 50 °C for 2 h, desiccated
and weighted until constant weight (considered as differences between
successive weights inferior to 1 mg). The measurements correspond to
two independent assays carried out in duplicate.
Tensile Strength and Shrinkage. Tensile strength resistance of
yarns was determined using a Tensile Tester Machine, accordingly to
ASTMD5035-90. Fabric tensile strength was determined using a P2000
Burst Strength Tester. All the samples were conditioned before testing
in a standard atmosphere. The tensile strength resistance values are
given as the mean of an n g 10 replicates, together with the standard
deviation (the coefficient of variation was below 10% for all cases).
Wool fabric shrinkage was determined after five 5A wash cycles
according to Woolmark method TM31.
Felting and Pilling. Felting and pilling of yarns were visually
evaluated after repeated washing (3×) at 50 °C, for 60 min and 20
rpm. For wool fabrics, samples were weighted and immediately placed
in a Pilling Box Machine type P.T.2 (Testrite Ltd., West Yorkshire,
England). The right sides of the samples were abraded under long-
abrasion cycles (18000) following BS 5811:1986. Fabric samples were
Figure 2. Fluorescence microscopy images of fiber cross sections
of wool yarns treated with FITC-labeled commercial Esperase (A) and
recombinant subtilsinE-VPAVG220 (B; 100×).
Figure 3. Formation of tyrosine (mM; open symbols) and total protein (%; closed symbols) for the enzymes Esperase (9, 0) and subtilisinE-
VPAVG220 (b,O). Release of free tyrosine is directly related to activity of the protease. Mean values of tyrosine formation were significantly
different compared with the subtilisinE-VPAVG220, p < 0.001.
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then rated by visual estimation according to the International Standard
ISO12945-2. Samples were compared with standard fabrics rated from
1 to 5, where one indicates the highest level of pill density.
Statistical Analysis. Data are expressed as means with standard
errors of the means (SE). A repeated measures ANOVA followed by
the Tukey’s post hoc test (GraphPad Prism 5.0 for Windows) was
employed to compare the effect of Esperase and subtilisinE-VPAVG220
in the formation of tyrosine with matched observations for time. In all
the other experiments One Way ANOVA was used. P values <0.05
were considered statistically significant.
Results and Discussion
Protein Expression and Purification. Escherichia coli
BL21(DE3) transformants carrying pET25:prosubtilisinE-
VPAVG220 grown and induced at 30 °C successfully expressed
the recombinant enzyme at high levels in the soluble fraction
(see Supporting Information, Figure 1A). The SDS-PAGE
analysis of the cellular lysate revealed the presence of a soluble
protein with a molecular weight greater than 116 kDa. In our
previous work we were not able to obtain native subtilisin E in
soluble fraction using the same expression system,15 which
suggests that the ELP fused with subtilisin E is acting as a
solubility tag, allowing the expression of soluble and processed
active enzyme (see Supporting Information, Figure 1C). This
finding allowed us to recover the recombinant enzyme in the
soluble fraction with no need of further solubilization and
renaturation steps. The different approaches of protein solubi-
lization, such as urea treatment, apart from being time-
consuming do not guarantee the yield of proteins with native
and active conformation. Thus, the strategy developed in this
work can also contribute to the production of other valuable
proteins that cannot be expressed using conventional E. coli
expression methodologies.
The obtained recombinant protein was efficiently purified by
metal-affinity chromatography and used for wool treatment
experiments (see Supporting Information, Figure 1B).
Differential Scanning Calorimetry (DSC) Analysis and
Morphological Characterization by Scanning Electron
Microscopy (SEM). DSC analysis was used for the determi-
nation of the transition temperature that was expected to occur
upon heating the sample. In the thermogram obtained during
the heating stage (HS; Figure 1A), the presence of an endo-
thermic peak is clearly evident which, in the range of the
temperatures analyzed, is the only thermal component of the
curve and is associated with the characteristic process of chain
folding and self-aggregating of ELPs.13 The transition temper-
ature (Tt) or temperature for self-assembling is identified with
the onset value of the peak and was calculated as approximately
31 °C for the subtilisinE-VPAVG220. These results are consistent
with data previously observed for a chemically synthesized
poly(VPAVG), where a Tt of approximately 30 °C was found.22
These results led us to speculate that the VPAVG220 chain is
conformationally free in the subtilisinE-VPAVG220 construction
and that the contribution arising from the subtilisin E amino
acid chain into the aggregation process and, thus, influencing
the Tt is minimal.
During the polymer cooling stage, reported in the lower curve
of Figure 1, the beginning of a sole exothermic component is
present around 10 °C, which is related to the dissolution of the
aggregates and rehydration of the polymer.13
Upon subtilisinE-VPAVG220 purification by temperature
shifts, the formation of a compact and dense structure is noticed
when heating the sample at 50 °C. After centrifugation and
drying of the assembled polymer the sample turned into a stiff
compact structure. Figure 1 shows SEM micrographs of
lyophilized/dehydrated polymer below (B) and above (C) the
Tt. Below the Tt the polymer appears in an essentially disordered
state, with structures resembling fibers. Above the Tt, the
difference is quite evident as the polymer self-aggregates into
compact sphere-like structures quite similar to a previously
described VPAVG polymer.13,22 This fact suggests that the
chimeric protein assembles into microstructures through its
elastin domain and free subtilisin E active domains.
Wool Enzymatic Treatment. In general, native subtilisins
have a molecular mass of approximately 30 kDa, which is the
major drawback on their application for wool treatment. Due
to their relatively small size, the enzymes can diffuse into the
fiber cortex causing the degradation of the internal parts of wool
structure. Based on literature, we postulated that an increase
greater than 4-fold on subtilisin E molecular weight would
prevent diffusion of enzyme into wool.7,8 A total of 0.85 U of
both commercial and recombinant enzymes were fluorescently
labeled with a fluorescent dye, FITC, and yarns were incubated
in these solutions for 24 h. The yarns were entrapped in a
nonfluorescent resin and sliced in thin layers with a microtome.
Fluorescence microscopy images show that FITC labeled
Esperase penetrated in some wool yarns due to heterogeneous
nature of wool fiber, while the enlarged recombinant subtilisinE-
VPAVG220, having a molecular weight above 116 kDa, appeared
to remain at the surface of yarns (Figure 2A,B).
Silva and collaborators have obtained similar results after
chemical modification of subtilisin with PEG and Eudragit
S-100.7,8 The chemically modified enzymes presented molecular
weights greater than 97 kDa which were effective to limit the
hydrolysis only at the wool cortex.7,8 Fluorescence microscopy
results provided a good indication that recombinant subtilisinE-
VPAVG220 effect is mainly restricted to wool’s surface.
The wool fiber’s cuticle is covered by a covalently bound
lipid layer, responsible for the high hydrophobicity of wool.
Alkaline pretreatments can partially remove some of these lipids,
Figure 4. Maximum tensile strength (N) and elongation (%) supported
by wool yarns subjected to different pretreatments treated with the
commercial Esperase and recombinant subtilisinE-VPAVG220.
Figure 5. SEM microphotographs of wool fabrics after the treatments:
(1) control; (2) Esperase; (3) genetically modified subtilisinE-
VPAVG220.
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reducing its hydrophobic nature and simultaneously enhancing
protein diffusion inside the fiber.23 Wool yarns were therefore
subjected to two alkaline pretreatments, a scouring washing (S),
and a scouring washing followed by bleaching (S + B). Wool
yarns previously pretreated were incubated with 0.85 U of either
Esperase or subtilisinE-VPAVG220 for 24 h for tensile strength
resistance evaluation. Regarding scoured wool fabrics, the
enzymatic treatment was performed using the same amount of
enzyme units for 5 h under orbital agitation.
Enzymatic hydrolysis of wool fabrics was determined in
terms of tyrosine equivalents (Figure 3). When the proteases
digest wool, the amino acid tyrosine is released along with
other amino acids and peptide fragments. Folin’s reagent
primarily reacts with free tyrosine to produce a blue colored
chromophore, which is quantifiable and measured as an
absorbance value on the spectrophotometer. The more
tyrosine that is released from wool, the more the chro-
mophores are generated and the stronger the activity of the
protease. Absorbance values generated by the activity of the
Esperase and the recombinant enzyme are compared to a
standard curve to correlate changes in absorbance with the
amount of tyrosine released. The subtilisinE-VPAVG220
showed very low release of tyrosine into the media. Compar-
ing to commercial Esperase, the amount of aminoacids
produced in tyrosine equivalents was significantly higher (p
< 0.001 for all time points), indicating wool fiber degradation
by the enzyme.
These results were also corroborated by the determination
of resistance in terms of tensile strength and elongation of the
samples. The maximum tensile strength supported by wool yarns
(Figure 4) and fabrics (Table 1) was drastically lower for
samples treated with Esperase, which promoted more than 50%
of reduction in the original samples tensile strength, indicating
higher fiber degradation as a consequence of enzyme diffusion.
Wool yarns incubated with 0.85 U of subtilisinE-VPAVG220
retained maximum tensile strength comparable to those of
control samples (without enzyme). Because the high molecular
weight subtilisinE-VPAVG220 is retained at the surface of wool
yarns with no diffusion of enzyme inside the fibers, only the
cuticle is under proteolytic attack, which can explain the higher
tensile strength of samples after enzymatic treatment.
Elongation values, displayed a high variability among the
different pretreatments. The parameter elongation is the ability
of the fiber to undergo deformation. Different studies have reveal
that the increase of the elongation of fiber wool after scouring
or scouring and bleaching treatments, keeping the original
resistance values, can be considered a normal behavior. Mild
conditions of scouring and bleaching, like we have used in our
experiments, can remove salt links and break the disulfide cross-
links, making the wool fiber easier to extend.1 This fact explains
why the elongation values display a high extent of variability
among the control and subtilisinE-VPAVG220 samples. This
effect is not observed in Esperase-treated samples where, due
to the decrease of resistance, almost no elongation is observed
before breaking the yarns.
Wool fabrics were also subjected to felting shrinkage tests
(5× 5A wash cycles). Control samples (no enzymatic treatment)
presented a shrinkage area greater than 6%. The antishrinkage
effect of Esperase (only 2.5% of shrinkage area) is quite obvious
and higher than antishrinkage effect induced by recombinant
subtilisinE-VPAVG220 (5%) when comparing both with the
control samples (Table 1). However, the antishrinkage effect
cannot be analyzed alone, as an independent characteristic.
Together with antishrinkage characteristics, weight loss and
resistance of fabrics are desirable properties that must be retained
in terms to meet consumer’s demands. This overall effect is
Table 1. Effect of Enzymatic Treatment on Wool Fabric Shrinkage and Resistance Determined in Terms of Weight Loss and Maximum
Pressure Supported by Samples
sample shrinkage (%) ( SEa weight loss (%) ( SE pressure (kPa) ( SE
control 6.1 ( 0.13 6.1 ( 0.37 519.4 ( 4.43
Esperase 2.5 ( 0.00b,d 18.4 ( 0.64e,g 111.1 ( 1.66h,i
subtilisinE-VPAVG220 5.0 ( 0.00c,d 8.8 ( 0.09f,g 513.5 ( 6.25i
a Mean values of shrinkage were significantly different compared with the respective control. b P < 0.001. c P < 0.01 and between the two enzymatic
treatments. d P < 0.001. Mean values of weight loss were significantly different compared with the respective control group. e P < 0.001, f P < 0.05 and
between the two enzymatic treatments. g P < 0.01. Mean values of pressure were significantly different compared with the respective control. h P < 0.001
and with the subtilisinE-VPAVG220. i P < 0.001.
Figure 6. Visual damage on wool yarns after three cycles washing in a Rotawash machine. (A) Wool yarns without enzyme; (B) wool yarns
treated with commercial Esperase; and (C) wool yarns treated with subtilisinE-VPAVG220.
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achieved only when the recombinant enzyme is used. The main
differences between enzymatic treatments were observed in the
fabric resistance, as mentioned above, as well as in the weight
loss.
Wool fabrics treated with 0.85 U of commercial Esperase
present the highest weight loss (more than 18%) compared to
samples treated with the same units of recombinant subtilisinE-
VPAVG220, which induced considerably less damage to the wool
fabric (in the order of 9%, respectively, for the same conditions;
Table 1). The damages observed in control samples (weight
losses of 6%) are due to the agitation promoted during samples
incubation for 5 h at 50 °C. High levels of mechanical agitation
associated with high temperature lead to some degree of fabric
damage and consequently to weight loss. The enzymatic
degradation of wool fibers by Esperase was quite significant.
This enzyme is able to penetrate into wool cortex and catalyze
different components of wool fibers. As shown in Figure 5, the
fibers suffered much less damage when the enzymatic treatment
was performed using the increased molecular weight enzyme,
meaning that the impact of degradation can be controlled by
the conditions of treatment. The fibers that were not degraded
had their cuticle layer removed, thus, improving their textile
properties.
To evaluate the damage of enzymatic treatment on wool yarns,
samples pretreated as previously described, and incubated with both
enzymes, were washed for three consecutive cycles in a Rotawash
machine. Pilling was visually evaluated (Figure 6).
Regarding the damage induced by enzymatic treatment on
wool fabrics, samples were subjected to 18000 cycles of abrasion
in a Pilling Box Machine. Pilling was visually evaluated and
rated from 1 to 5.
Both pretreatments seemed to induce a slight degree of
damage on wool yarns. This degradation was more extensive
when commercial Esperase was used. Wool fabrics treated with
Esperase also presented a higher level of felting and pilling
(Level 1) than samples treated with recombinant subtilisinE-
VPAVG220 (Level 4, data not shown).
In fact, samples treated with subtilisinE-VPAVG220 felted
even less than the control samples (Level 1 of felting and pilling,
data not shown), which emphasizes the idea that, due to its size,
the hydrolytic activity of subtilisinE-VPAVG220 is restricted to
the surface of wool fibers, and that the elastomeric polymer
VPAVG220 can provide protection of yarns and fabrics against
excessive damage.
Conclusions
Enzymes can play an important role in the development of
novel technologies for wool finishing bioprocesses at an
industrial level. In particular, modified proteases have been
described as a promising alternative for wool finishing, because
they can represent an effective way of removing wool scales
and can be an ecological option to the conventional chlorine
treatments.6-8
In this work, we have attained the production of a recombi-
nant high molecular weight subtilisin E for wool finishing
through the fusion of subtilisin E gene with a sequence coding
for an elastin-based polymer. The interest in the application of
these polymers in diverse areas of industry is continuously
growing. This new class of materials has many advantages over
the conventional petroleum-based polymers: they can be ob-
tained by chemical synthesis and by recombinant DNA technol-
ogy involving gene construction, Escherichia coli transformation
and expression by fermentation.24,25
The effect of recombinant high molecular weight subtilisinE-
VPAVG220 was first assessed on wool yarns and subsequently
on wool fabrics, and compared to the effect of commercial
Esperase. As expected, due to its small size, Esperase was able
to penetrate inside the wool cortex, damaging the fiber. In
contrast, the subtilisinE-VPAVG220 hydrolyzed just the cuticle
layer of wool. Both yarns and fabrics treated with engineered
enzyme presented higher tensile strength and lower felting and
pilling, along with lower weight loss, as well as better dyeing.
Recombinant enzyme seems also to impart wool fabrics
shrinkage resistance properties.
Although this study clearly illustrates the potential advantage
in using the protein-based polymer VPAVG220 for functional-
ization of subtilisin E for wool finishing, the approach used in
this investigation can be further optimized. For example,
thermally responsive elastin-based polymers like VPAVG220
undergo an inverse phase transition. Below their inverse
transition temperature (Tt; near 30 °C for VPAVG220) ELPs are
structurally disordered, highly solvated, and thus, soluble in
aqueous solutions; above Tt, the polymer gradually precipitates
as a consequence of the formation of intramolecular contacts
between nonpolar regions.26-28 Therefore, VPAVG220 can be
used not only to functionalize subtilisin E by increasing its
molecular weight, but the reversible soluble-insoluble phase
transition behavior of this polymer can also be exploited to
develop a simple and nonchromatographic method for purifica-
tion of the recombinant subtilisinE-VPAVG220. This method of
purification of ELP fusion proteins has previously been reported
and termed inverse transition cycling (ITC).29,30 Using this
method, the recombinant subtilisinE-VPAVG220 can be selec-
tively purified from other E. coli proteins by sequential and
repeated cycles of aggregation, centrifugation, and resolubili-
zation of recombinant protein.26 The ranges of temperatures that
can be employed for an efficient subtilisinE-VPAVG220 purifica-
tion, without irreversible denaturation of the fusion protein, are
currently being investigated. After optimization, this procedure
can easily be scaled up to accommodate larger culture volumes,
making this technique highly competitive against any conven-
tional chromatographic process.
Overall, we have developed a new high molecular weight
subtilisinE-VPAVG220, which represents a breakthrough in wool
finishing treatment, promising as an ecological alternative to
the traditional highly polluting Chlorine/Hercosett treatment,
used in textile industry.
In addition, nowadays detergent enzymes account for 89%
of the total protease sales in the world and a significant share
of the market is captured by subtilisins from Bacillus species.
The new recombinant enzyme produced by our work group can
be included in new detergent formulations that can be used to
wash all kinds of garments, including silk and wool.
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